A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients.
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Gallium nitrate (Primary)
- Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
- Focus Adverse reactions; Pharmacokinetics
- 16 May 2018 Status changed from active, no longer recruiting to completed.
- 14 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Jun 2012 Actual patient number is 20 as reported by ClinicalTrials.gov.